BABA

Alibaba Group Holding Limited

53
Fundamentals36/ 100
Valuation50/ 100
Upside potential58/ 100
Risk potential23/ 100

BABA has a slight edge over HVT overall, supported by stronger valuation.

HVT

Haverty Furniture Companies, Inc.

50
Fundamentals52/ 100
Valuation18/ 100
Upside potential59/ 100
Risk potential18/ 100

HVT has lower modeled downside risk, despite its lower overall score.

BABA Fundamentals

MetricStatus
Stable
Under pressure
Weak
Healthy

BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.

HVT Fundamentals

MetricStatus
Unavailable
Stable
Stable
Strong

HVT's balance sheet is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its revenue.

BABA PE Valuation

CHEAPFAIREXPENSIVE9.3x19x28x37x
CHEAPFAIREXPENSIVE9.3x19x28x37x
LevelPEPriceVs current
Cheap16x$69.66-26%
Fair20x$86.59-8.2%
Current21x$94.36—
Expensive26x$115+22%

Historical ranges are pointers, not guarantees.

BABA has the edge over HVT in the historical PE scenario, which offers more potential upside but is not a forecast.

HVT PE Valuation

CHEAPFAIREXPENSIVE5.3x11x16x21x
CHEAPFAIREXPENSIVE5.3x11x16x21x
LevelPEPriceVs current
Cheap5.9x$8.85-66%
Fair9.8x$14.54-44%
Forward15x$25.99—
Expensive16x$23.69-8.8%
Current17x$25.99—

Historical ranges are pointers, not guarantees.

HVT's PE is in its expensive range at 17x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.

BABA Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Limited
Low

Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.

HVT Forward outlook

MetricOutlook
Improving
Strong growth
Growth
Improving
Limited
Low

Analysts expect earnings and revenue growth for HVT, with profitability improving. However, they disagree widely on these estimates.

BABA Risk to reward

ScenarioChangePrice
Upside+33%$125.09
Downside-23%$72.35

Calculated from the latest close: $94.36 on Nov 12.

BABA trails HVT on modeled risk to reward, with less potential upside relative to its potential downside.

HVT Risk to reward

ScenarioChangePrice
Upside+26%$32.78
Downside-18%$21.27

Calculated from the latest close: $25.99 on Nov 12.

HVT has a better modeled risk to reward balance than BABA, with more potential upside relative to its potential downside.

BABA Earnings Per Share

Q3 2023: $8.12Q4 2023: $6.04Q1 2024: $4.71Q2 2024: $4.29Q3 2024: $5.26Q4 2024: $7.47Q1 2025: $8.06Q2 2025: $9.27Q3 2025: $7.85Q4 2025: $5.79Q1 2026: $6.57Q2 2026: $4.42
Q3 2023: $8.12Q4 2023: $6.04Q1 2024: $4.71Q2 2024: $4.29Q3 2024: $5.26Q4 2024: $7.47Q1 2025: $8.06Q2 2025: $9.27Q3 2025: $7.85Q4 2025: $5.79Q1 2026: $6.57Q2 2026: $4.42
QuarterTTM EPSYoY
Q2 2026$4.42-52%
Q1 2026$6.57-18%
Q4 2025$5.79-22%
Q3 2025$7.85+49%
Q2 2025$9.27+116%
Q1 2025$8.06+71%
Q4 2024$7.47+24%
Q3 2024$5.26-35%

HVT has the stronger earnings trend. Trailing diluted EPS is down 52% for BABA versus HVT down 6.9%.

HVT Earnings Per Share

Q4 2023: $3.36Q1 2024: $2.76Q2 2024: $2.33Q3 2024: $1.60Q4 2024: $1.19Q1 2025: $1.28Q2 2025: $1.17Q3 2026: $1.49Forward: $1.79
Q4 2023: $3.36Q1 2024: $2.76Q2 2024: $2.33Q3 2024: $1.60Q4 2024: $1.19Q1 2025: $1.28Q2 2025: $1.17Q3 2026: $1.49Forward: $1.79
QuarterTTM EPSYoY
Forward$1.79+20%
Q2 2025$1.17-50%
Q1 2025$1.28-54%
Q4 2024$1.19-65%
Q3 2024$1.60-59%
Q2 2024$2.33-46%
Q1 2024$2.76-44%
Q4 2023$3.36-36%
Q3 2023$3.88-25%

HVT's earnings per share have fallen from their peak: $1.49 over the past year, against $5.26 in late 2022.

BABA Quarterly Revenue

Q3 2023: $33.7BQ4 2023: $39.1BQ1 2024: $33.3BQ2 2024: $36.5BQ3 2024: $35.5BQ4 2024: $42BQ1 2025: $35.5BQ2 2025: $37.2BQ3 2025: $37.2BQ4 2025: $42.7BQ1 2026: $36.5BQ2 2026: $40.2B
Q3 2023: $33.7BQ4 2023: $39.1BQ1 2024: $33.3BQ2 2024: $36.5BQ3 2024: $35.5BQ4 2024: $42BQ1 2025: $35.5BQ2 2025: $37.2BQ3 2025: $37.2BQ4 2025: $42.7BQ1 2026: $36.5BQ2 2026: $40.2B
QuarterRevenueYoY
Q2 2026$40.2B+8.3%
Q1 2026$36.5B+2.9%
Q4 2025$42.7B+1.7%
Q3 2025$37.2B+4.8%
Q2 2025$37.2B+1.8%
Q1 2025$35.5B+6.6%
Q4 2024$42B+7.6%
Q3 2024$35.5B+5.2%

HVT has the stronger quarterly revenue trend. Revenue is up 8.3% for BABA versus up 12% for HVT.

HVT Quarterly Revenue

Q4 2023: $211MQ1 2024: $184MQ2 2024: $179MQ3 2024: $176MQ4 2024: $184MQ1 2025: $182MQ2 2025: $181MQ3 2025: --Q4 2025: $202MQ1 2026: $189MQ2 2026: $195MQ3 2026: $203M
Q4 2023: $211MQ1 2024: $184MQ2 2024: $179MQ3 2024: $176MQ4 2024: $184MQ1 2025: $182MQ2 2025: $181MQ3 2025: --Q4 2025: $202MQ1 2026: $189MQ2 2026: $195MQ3 2026: $203M
QuarterRevenueYoY
Q2 2026$194.9M+7.7%
Q1 2026$189.1M+4.1%
Q4 2025$201.9M+9.5%
Q2 2025$181M+1.3%
Q1 2025$181.6M-1.3%
Q4 2024$184.4M-13%
Q3 2024$175.9M-20%
Q2 2024$178.6M-13%

HVT's revenue is recovering but still below its 2022 peak: $203M last quarter, up 12% from the same quarter a year ago.

BABA Free Cash Flow

Q3 2023: $5.4BQ4 2023: $11BQ1 2024: $34MQ2 2024: $3.2BQ3 2024: $2.1BQ4 2024: $10.4BQ1 2025: −$4.2BQ2 2025: −$2.7BQ3 2025: −$3.2BQ4 2025: $1BQ1 2026: −$2.7BQ2 2026: −$6.7B
Q3 2023: $5.4BQ4 2023: $11BQ1 2024: $34MQ2 2024: $3.2BQ3 2024: $2.1BQ4 2024: $10.4BQ1 2025: −$4.2BQ2 2025: −$2.7BQ3 2025: −$3.2BQ4 2025: $1BQ1 2026: −$2.7BQ2 2026: −$6.7B
QuarterFree cash flowYoY
Q2 2026-$6.7B-$4.1B
Q1 2026-$2.7B+$1.5B
Q4 2025$1B-90%
Q3 2025-$3.2B-254%
Q2 2025-$2.7B-182%
Q1 2025-$4.2B-12231%
Q4 2024$10.4B-4.8%
Q3 2024$2.1B-62%

HVT has the stronger cash trend. Its trailing FCF is down 34% versus its history, compared with BABA at down 158%.

HVT Free Cash Flow

Q4 2023: $11MQ1 2024: −$3MQ2 2024: $5MQ3 2024: $16MQ4 2024: $9MQ1 2025: $27,000Q2 2025: $2MQ3 2025: --Q4 2025: $3MQ1 2026: −$10MQ2 2026: $18MQ3 2026: $21M
Q4 2023: $11MQ1 2024: −$3MQ2 2024: $5MQ3 2024: $16MQ4 2024: $9MQ1 2025: $27,000Q2 2025: $2MQ3 2025: --Q4 2025: $3MQ1 2026: −$10MQ2 2026: $18MQ3 2026: $21M
QuarterFree cash flowYoY
Q2 2026$18.1M+996%
Q1 2026-$9.9M-36600%
Q4 2025$3M-67%
Q2 2025$1.6M-66%
Q1 2025$27K+$3.3M
Q4 2024$9.1M-18%
Q3 2024$16.1M-52%
Q2 2024$4.9M+$9.6M

HVT still generates free cash flow, though less than at its 2020 peak: $32M over the past year.

BABA Total Shares

Q3 2023: 2.6BQ4 2023: 2.5BQ1 2024: 2.5BQ2 2024: 2.4BQ3 2024: 2.4BQ4 2024: 2.4BQ1 2025: 2.4BQ2 2025: 2.4BQ3 2025: 2.4BQ4 2025: 2.4BQ1 2026: 2.4BQ2 2026: 2.4B
Q3 2023: 2.6BQ4 2023: 2.5BQ1 2024: 2.5BQ2 2024: 2.4BQ3 2024: 2.4BQ4 2024: 2.4BQ1 2025: 2.4BQ2 2025: 2.4BQ3 2025: 2.4BQ4 2025: 2.4BQ1 2026: 2.4BQ2 2026: 2.4B
PeriodChange %Net change
Quarterly+0.5%+11.1M shares
1 year+0.9%+21.4M shares
3 years-6.2%-161M shares
5 years-12%-339M shares
Available history-8.4%-221M shares

BABA has 2.4B diluted shares, up 0.9% from a year ago.

HVT Total Shares

Q4 2023: 17MQ1 2024: 17MQ2 2024: 17MQ3 2024: 17MQ4 2024: 17MQ1 2025: 16MQ2 2025: 16MQ4 2025: 16MQ1 2026: 16MQ2 2026: 16MQ3 2026: 16M
Q4 2023: 17MQ1 2024: 17MQ2 2024: 17MQ3 2024: 17MQ4 2024: 17MQ1 2025: 16MQ2 2025: 16MQ4 2025: 16MQ1 2026: 16MQ2 2026: 16MQ3 2026: 16M
PeriodChange %Net change
Quarterly-5.1%-832K shares
1 year-5.1%-832K shares
3 years-6.9%-1.2M shares
5 years-17%-3.2M shares
Available history-21%-4.1M shares

HVT has the edge over BABA on shareholder dilution, with a more favorable share count trend.

BABA Net Leverage

Q3 2023: -0.6xQ4 2023: -0.8xQ1 2024: -0.4xQ2 2024: -0.4xQ3 2024: -0.2xQ4 2024: 0.1xQ1 2025: 0.3xQ2 2025: 0.2xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.5xQ2 2026: 0.5x
Q3 2023: -0.6xQ4 2023: -0.8xQ1 2024: -0.4xQ2 2024: -0.4xQ3 2024: -0.2xQ4 2024: 0.1xQ1 2025: 0.3xQ2 2025: 0.2xQ3 2025: 0.8xQ4 2025: 0.6xQ1 2026: 0.5xQ2 2026: 0.5x
QuarterNet LeverageStatus
Q2 20260.5xVery low
Q1 20260.5xVery low
Q4 20250.6xVery low
Q3 20250.8xVery low
Q2 20250.2xVery low
Q1 20250.3xVery low
Q4 20240.1xVery low
Q3 2024-0.2xNet Cash

BABA's net debt is less than a year of its operating earnings (EBITDA).

HVT Net Leverage

Q4 2023: 1.1xQ1 2024: 1.3xQ2 2024: 1.5xQ3 2024: 1.7xQ4 2024: 2.1xQ1 2025: 2.1xQ2 2025: 2.1xQ3 2026: -2.1x
Q4 2023: 1.1xQ1 2024: 1.3xQ2 2024: 1.5xQ3 2024: 1.7xQ4 2024: 2.1xQ1 2025: 2.1xQ2 2025: 2.1xQ3 2026: -2.1x
QuarterNet LeverageStatus
Q3 2026-2.1xNet Cash
Q2 20252.1xModerate
Q1 20252.1xModerate
Q4 20242.1xModerate
Q3 20241.7xHealthy
Q2 20241.5xHealthy
Q1 20241.3xHealthy
Q4 20231.1xHealthy

HVT has the edge over BABA on leverage, with a lower net debt burden relative to earnings.

BABA Weekly Momentum

MetricValueStatus
RSI38.0Neutral
Stochastic12.7Oversold

BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).

HVT Weekly Momentum

MetricValueStatus
RSI48.6Neutral
Stochastic36.5Neutral

HVT's weekly RSI is 49 (neutral) and its Stochastic is 36 (neutral).

BABA PE vs Consumer Cyclical Sector

MetricBABASector medianRelative
PE21x18x19% above
PE %604713 pts above

BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.

HVT PE vs Consumer Cyclical Sector

MetricHVTSector medianRelative
PE17x18x2.9% below
PE %954748 pts above

HVT has the edge over BABA on valuation relative to its sector.

BABA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$104.79.9% below
20 week MA$111.115% below
50 week MA$128.026% below
100 week MA$127.726% below
200 week MA$106.411% below

BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.

HVT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$27.65.8% below
20 week MA$27.14.1% below
50 week MA$25.03.8% above
100 week MA$23.212% above
200 week MA$26.62.1% below

HVT has the edge over BABA on trend strength, trading above more of its moving averages.

BABA Yearly ROI

YearStart priceEnd priceROI
2020$215.5$222.0+3%
2021$222.0$118.7-47%
2022$118.7$85.7-28%
2023$85.7$77.5-9.5%
2024$77.5$85.1+9.7%
2025$85.1$152.2+79%
2026 YTD$152.2$94.4-38%

BABA has finished lower in three of the last six years. It's down 38% so far in 2026.

HVT Yearly ROI

YearStart priceEnd priceROI
2020$20.1$28.4+41%
2021$28.4$30.5+7.5%
2022$30.5$30.7+0.7%
2023$30.7$35.5+16%
2024$35.5$22.1-38%
2025$22.1$24.1+9%
2026 YTD$24.1$26.0+7.8%

HVT has the edge over BABA on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key